1310357-08-4

Upstream product

• 185981-82-2 1-(benzyloxy)-5-bromo-2,4-dimethoxy-3-methylbenzene 
• 105103-87-5 5-bromo-2,4-dimethoxy-3-methylphenol 
• 622-30-0 N-benzyl hydroxylalmine 
• 100-39-0 benzyl bromide 
• 95715-87-0 (R)-3-tert-butoxycarbonyl-4-formyl-2,2-dimethyloxazolidine 
• 1002095-29-5 C₁₈H₂₆N₂O₄ 
• 1002095-33-1 C₄₂H₅₀N₂O₈ 
• 1002095-31-9 C₃₄H₄₄N₂O₇ 
• 1002095-50-2 C₃₉H₄₆N₂O₈ 
• 17257-71-5 (S)-Mosher acid 

Relevant academic research and scientific papers

Asymmetric [C + NC + CC] coupling entry to the naphthyridinomycin natural product family: Formal total synthesis of cyanocycline A and bioxalomycin β2

A full account of our [C + NC + CC] coupling approach to the naphthyridinomycin family of natural products is presented, culminating in formal total syntheses of cyanocycline A and bioxalomycin β2. The key complexity-building reaction in the synthesis involves the Ag I-catalyzed endo-selective [C + NC + CC] coupling of aldehyde 7, (S)-glycyl sultam 8, and methyl acrylate (9) to provide the highly functionalized pyrrolidine 6, which was carried forward to an advanced intermediate (compound 33) in Fukuyama's synthesis of cyanocycline A. Since cyanocycline A has been converted to bioxalomycin β2, this constitutes a formal synthesis of the latter natural product as well. The multicomponent reaction-based strategy reduces the number of steps previously needed to assemble these complex molecular targets by one-third. This work highlights the utility of the asymmetric [C + NC + CC] coupling reaction in the context of a complex pyrrolidine-containing target and provides an illustrative guide for its application to other synthesis problems. The synthesis also fueled collaborative biological and biochemical research that identified a unique small molecule inhibitor of cell migration (compound 30).